Skip left side navigation and go to content

Need Help?
Chat with us live!

Chat with us live, Monday through Friday, 8:30 a.m. to 5 p.m. eastern time, or call us at 301’Äì592’Äì8573.

Pediatric Cardiovascular Risk Reduction Guidelines
Financial and Other Disclosures

Development of the guideline was funded by the NHLBI, NIH. Expert Panel members completed financial disclosure forms, and the Expert Panel members disclosed relevant financial interests to each other prior to their discussions. Expert Panel members participated as volunteers and were reimbursed only for travel expenses related to the Expert Panel meetings. Financial disclosure information covering the period during which the guideline was developed is provided for each Expert Panel member below.

Dr. Benuck has no relevant financial interests.

Dr. Christakis has no relevant financial interests.

Dr. Daniels has served as a consultant to Abbott Laboratories. He has received funding/grant support for research projects from the NIH.

Dr. Dennison has no relevant financial interests.

Dr. Gidding has no relevant financial interests.

Dr. Gillman has no relevant financial interests.

Dr. Gottesman has served on the Health Advisory Board, Child Development Council of Franklin County and as a consultant to Early Head Start and Head Start for Region 5B. She has written for iVillage and taught classes through Garrison Associates for the State of Ohio, Bureau of Early Intervention Services' Help Me Grow Program. She has received funding/grant support for research projects from the NIH.

Dr. Kwiterovich has served as a consultant or advisory board member for Merck, Schering-Plough, Pfizer, Sankyo, and Astra Zeneca. He has served in the Speakers' Bureaus of Merck, Schering-Plough, Pfizer, Sankyo, KOS, and Astra Zeneca. He has received funding/grant and contract support for research projects from Pfizer, Sankyo Pharma, and Schering-Plough Research Institute.

Dr. McBride has served as a consultant or advisory board member for BMS and Merck. He has served in the Speakers' Bureaus of KOS, Merck, and Pfizer.

Dr. McCrindle has received funding/grant support for research projects from Astra Zeneca, Sankyo, and Schering.

Dr. Rocchini has no relevant financial interests.

Dr. Urbina has no relevant financial interests.

Dr. Van Horn has provided advice to Chartwells School Food Service. She has owned stock in the Vanguard 500 Index, TIAA/CREF Stock Fund, TIAA/CREF Group Fund, Pioneer Cullen Value Fund, Marisco Focus Fund, Fruit Eagle Overseas Fund, Causeway International Fund, and Bemis Company. She has received funding/grant and contract support for research projects from the NIH and General Mills.

Dr. Washington has no relevant financial interests.


Skip footer links and go to content